Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Albertstr. 9, 79104 Freiburg, Germany; Hermann Staudinger Graduate School, University of Freiburg, Hebelstr. 27, 79104 Freiburg, Germany.
Synex Synthetics BV, Karveelweg 20, 6222 NH Maastricht, The Netherlands.
J Pharm Biomed Anal. 2019 Sep 10;174:270-276. doi: 10.1016/j.jpba.2019.05.062. Epub 2019 May 28.
A variety of hallucinogens of the lysergamide type has emerged on the drug market in recent years and one such uncontrolled derivative of lysergic acid diethylamide (LSD) is 1-propionyl-LSD (1P-LSD). Due to the high potency of LSD and some of its derivatives (common doses: 50-200 μg), sensitive methods are required for the analysis of biological samples such as serum and urine. The occurrence of an intoxication case required the development of a fully validated, highly sensitive method for the quantification of 1P-LSD and LSD in urine and serum using LC-MS/MS. Given that LSD is unstable in biological samples when exposed to light or elevated temperatures, we also conducted stability tests for 1P-LSD in urine and serum under different storage conditions. The validation results revealed that the analysis method was accurate and precise with good linearity over a wide calibration range (0.015-0.4 ng mL). The limit of detection (LOD) and the lower limit of quantification (LLOQ) of 1P-LSD and LSD in serum and urine were 0.005 ng mL and 0.015 ng mL, respectively. The stability tests showed no major degradation of 1P-LSD in urine and serum stored at -20 °C, 5 °C or at room temperature for up to five days, regardless of protection from light. However, LSD was detected in all samples stored at room temperature showing a temperature-dependent hydrolysis of 1P-LSD to LSD to some extent (up to 21% in serum). Serum samples were particularly prone to hydrolysis possibly due to enzymatically catalyzed reactions. The addition of sodium fluoride prevented the enzymatic formation of LSD. The method was applied to samples obtained from the intoxication case involving 1P-LSD. The analysis uncovered 0.51 ng mL LSD in urine and 3.4 ng mL LSD in serum, whereas 1P-LSD remained undetected. So far pharmacokinetic data of 1P-LSD is missing, but with respect to the results of our stability tests and the investigated case rapid hydrolysis to LSD in-vivo seems more likely than instabilities of 1P-LSD in urine and serum samples.
近年来,市场上出现了多种类型的致幻剂,其中一种麦角酰二乙胺(LSD)的未经管制衍生物是 1-丙酰基-LSD(1P-LSD)。由于 LSD 和一些其衍生物(常见剂量:50-200μg)的效力较高,因此需要使用灵敏的方法来分析血清和尿液等生物样本。由于出现了中毒案例,因此需要开发一种完全经过验证的、灵敏的 LC-MS/MS 方法,用于定量检测尿液和血清中的 1P-LSD 和 LSD。鉴于 LSD 在生物样本中暴露于光或高温时不稳定,我们还在不同储存条件下对尿液和血清中的 1P-LSD 进行了稳定性测试。验证结果表明,该分析方法具有良好的线性度,准确度和精密度均较高,校准范围较宽(0.015-0.4ng/mL)。血清和尿液中 1P-LSD 和 LSD 的检测限(LOD)和定量下限(LLOQ)分别为 0.005ng/mL 和 0.015ng/mL。稳定性测试表明,尿液和血清中的 1P-LSD 在-20°C、5°C 或室温下储存长达五天,无论是否避光,均未发生明显降解。然而,在所有室温储存的样本中均检测到 LSD,表明 1P-LSD 会在一定程度上(血清中高达 21%)发生依赖于温度的水解生成 LSD。血清样本特别容易发生水解,这可能是由于酶促反应所致。添加氟化钠可防止 LSD 的酶促形成。该方法应用于涉及 1P-LSD 的中毒案例获得的样本。分析结果显示,尿液中 LSD 含量为 0.51ng/mL,血清中 LSD 含量为 3.4ng/mL,而 1P-LSD 未检出。到目前为止,1P-LSD 的药代动力学数据尚不清楚,但鉴于我们的稳定性测试结果和所调查的案例,体内迅速水解为 LSD 的可能性似乎大于尿液和血清样本中 1P-LSD 的不稳定性。